Astec Lifesciences Ltd

Astec Lifesciences Ltd, a key player in the Pesticides & Agrochemicals sector, recorded significant trading volumes and value turnover on 3 December 2025, reflecting heightened market interest and notable price movements that outpaced sector benchmarks.

Astec Lifesciences demonstrated a robust intraday performance on 3 December 2025, touching a high of ₹862.95, marking an 8.2% rise during the trading session. This surge stands out amid a broadly negative market environment, with the Sensex declining by 0.28% on the day.

Astec Lifescienc has undergone a revision in its market evaluation, reflecting a shift in analytical perspective driven by recent financial and technical developments. The company, operating within the Pesticides & Agrochemicals sector, faces a complex backdrop marked by operational losses and subdued market performance.

Astec Lifesciences Ltd, a key player in the Pesticides & Agrochemicals sector, has emerged as one of the most actively traded stocks by value on 26 Nov 2025, reflecting significant investor interest despite a modest decline in its share price. The stock’s trading activity, combined with its performance relative to sector and benchmark indices, offers a nuanced picture of market dynamics in this segment.

Astec Lifesciences Ltd, a key player in the Pesticides & Agrochemicals sector, has emerged as one of the most actively traded stocks by value on 25 Nov 2025. The stock demonstrated notable market interest with a total traded volume exceeding 44 lakh shares and a turnover surpassing ₹404 crore, reflecting heightened investor participation and liquidity in the small-cap segment.

Astec Lifesciences Ltd, a key player in the Pesticides & Agrochemicals sector, has emerged as one of the most actively traded stocks by volume on 24 Nov 2025, registering a significant surge in market activity. The stock’s performance has outpaced its sector peers and the broader market indices, reflecting heightened investor interest and notable price movements within a volatile trading range.

Astec Lifesciences demonstrated robust intraday performance on 24 Nov 2025, reaching a day’s high of Rs 888, marking a 7.36% rise from its previous close. The stock outpaced its sector and broader market indices, reflecting notable trading momentum in the pesticides and agrochemicals segment.

Astec Lifesciences Ltd, a key player in the Pesticides & Agrochemicals sector, has emerged as one of the most actively traded stocks by value on 24 Nov 2025. The stock demonstrated significant volatility and strong investor participation, reflecting heightened market interest and dynamic trading patterns.

Astec Lifesciences has exhibited a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. The stock’s recent price action, combined with evolving technical parameters, offers a nuanced perspective on its near-term trajectory within the Pesticides & Agrochemicals sector.

Astec Lifesciences Ltd, a key player in the Pesticides & Agrochemicals sector, has emerged as one of the most actively traded stocks by value on 21 Nov 2025. The stock recorded a total traded volume exceeding 40 lakh shares with a turnover surpassing ₹311 crore, reflecting heightened investor interest and significant market activity.

Astec Lifesciences Ltd, a key player in the Pesticides & Agrochemicals sector, has emerged as one of the most actively traded stocks by volume on 21 Nov 2025. The stock recorded a total traded volume exceeding 40 lakh shares, reflecting heightened investor interest and significant market activity. This surge in trading volume accompanies a notable price movement, positioning Astec Lifesciences as a focal point for market participants today.

Astec Lifesciences demonstrated robust intraday performance on 21 Nov 2025, reaching a day’s high of Rs 785, reflecting a 6.65% rise during trading hours. The stock outpaced its sector and broader market indices, marking a notable surge amid a mixed market backdrop.

Astec Lifesciences demonstrated robust intraday performance on 20 Nov 2025, touching a day’s high of Rs 670.6, reflecting a 7.08% rise during the trading session. The stock outpaced its sector and broader market indices, supported by heightened volatility and active trading.

Astec Lifesciences has hit a new 52-week low, reflecting ongoing challenges in the Pesticides & Agrochemicals sector. The company has reported negative results for six consecutive quarters, with declining stock performance and high debt levels raising concerns about its financial stability and market position.

Astec Lifesciences has hit a new 52-week low, reflecting ongoing challenges in the pesticides and agrochemicals sector. The company has experienced a significant decline in stock value over the past year, coupled with negative financial performance and operational difficulties, including six consecutive quarters of losses.

Astec Lifesciences has hit a new 52-week low, reflecting ongoing struggles in its financial performance. The company has faced consistent challenges, including six consecutive quarters of negative results and a high Debt to EBITDA ratio, contributing to a significant decline in its stock over the past year.